Litcius/Paper detail

Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)

Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, Natascia Caroccia, Milo Gatti, Beatrice Tazza, Clara Solera Horna, Maddalena Giannella, Pierluigi Viale

2023International Journal of Antimicrobial Agents11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTolerabilityAdverse effectSurgeryInternal medicineAbdominal surgeryClinical endpointSeptic shockSepsisGastroenterologyClinical trialAntifungal resistance and susceptibilitySepsis Diagnosis and TreatmentParasites and Host Interactions
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study) | Litcius